[Molecular targeted therapy in adult T-cell leukemia/lymphoma].
Mori
Naoki
N
Division of Molecular Virology and Oncology, Graduate School of Medicine, University of the Ryukyus.
D000328:Adult; D000954:Antigens, Surface / Q000276:immunology; D018841:HSP90 Heat-Shock Proteins / Q000037:antagonists & inhibitors; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy*; D016328:NF-kappa B / Q000037:antagonists & inhibitors; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors
D000954:Antigens, Surface; D018841:HSP90 Heat-Shock Proteins; D016328:NF-kappa B; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011505:Protein-Tyrosine Kinases